Center for Dialysis Innovation

About:

Center for Dialysis Innovation enhances the health and well-being of patients starting and undergoing dialysis.

Top Investors: Northwest Kidney Centers

Description:

Center for Dialysis Innovation aims to use biomaterial and bioengineering technologies to transform dialysis care. It envisions that future dialysis therapy will be free of complications and will completely restore kidney health. Focused on reducing complications, the center undertakes a comprehensive technical redesign of dialysis treatment with patient well-being, independence, and self-care autonomy as goals using biomaterials and bioengineering. The Center for Dialysis Innovation opened in November 2016 through a partnership between Northwest Kidney Centers, UW Medicine and the University of Washington. It is led by co-directors Jonathan Himmelfarb, director of the UW’s Kidney Research Institute, and Buddy Ratner, a professor of bioengineering and chemical engineering.

Total Funding Amount:

$15M

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)cdi.washington.edu

Founders:

Buddy Ratner, Jonathan Himmelfarb

Number of Employees:

11-50

Last Funding Date:

2017-03-14

IPO Status:

Private

Industries: